Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib in Glucocorticoid Resistant ICIs-related Myocarditis
NCT06393972Phase 2Completed
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Apr 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tofacitinib oral solution in myocarditis, sponsored by Zhongshan Hospital, Fudan University. Started Apr 2024; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
myocarditis
Beyond the preview
Go deeper on NCT06393972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06393972.